Inloggad som:
avslutad_IDUNN
Är du som patient intresserad av mer information om en studie, kontakta din behandlande läkare.
avslutad_IDUNN
A Randomised, Open-label, Multicentre, Phase 3 Trial of First-line Treatment with Mesenchymal Stromal Cells MC0518 Versus Best Available Therapy in Adult and Adolescent Subjects with Steroid-refractory Acute Graft-versus-host Disease After Allogeneic Haematopoietic Stem Cell Transplantation (IDUNN Trial)
A Randomised, Open-label, Multicentre, Phase 3 Trial of First-line Treatment with Mesenchymal Stromal Cells MC0518 Versus Best Available Therapy in Adult and Adolescent Subjects with Steroid-refractory Acute Graft-versus-host Disease After Allogeneic Haematopoietic Stem Cell Transplantation (IDUNN Trial)
Karolinska Universitetssjukhuset / Hematologisk vård
Mer information om studien för vårdgivare
Studien ändrades senast: (2025-10-28)